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Abstract Bioreactors hold a lot of promise for tissue
engineering and regenerative medicine applications.
They have multiple uses including cell cultivation for
therapeutic production and for in vitro organ mod-
elling to provide a more physiologically relevant
environment for cultures compared to conventional
static conditions. Bioreactors are often used in com-
bination with scaffolds as the nutrient flow can
enhance oxygen and diffusion throughout the 3D
constructs to prevent the formation of necrotic cores.
A variety of scaffolds have been fabricated to achieve
a structural architecture that mimic native extracellu-
lar matrix. Future developments of in vitro models will
incorporate the ability to non-invasively monitor the
cellular microenvironment to enhance the understand-
ing of in vitro conditions. This review details current
advancements in bioreactor and scaffold systems and
provides insight on how in vitro models can be
augmented for future biomedical applications.
Keywords Bio-sensing  Bioreactor  Extracellular
matrix  Nanosensors  Regenerative medicine 
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Introduction
Tissue engineering is the science of repairing, replac-
ing and enhancing functional properties of biological
tissue, such as diseased or damaged organs, through
the combination of cells, biologically active mole-
cules, synthetic and innate biological components
(The National Institute of Biomedical Imaging and
Bioengineering 2016; Katari et al. 2015; Okamoto and
John 2013).
Tissue engineered constructs can act as model
systems that permit investigation and mimic specific
cellular processes and interactions to further improve
our understanding and subsequently develop future
therapeutics. The development of in vitro tissue
models allows predictions on drug activity, metabo-
lism and toxicity in vivo to bemade which is important
for drug discovery (Maltman and Przyborski 2010).
The pharmaceutical industry in particular is in need of
more physiologically relevant and accurate models
due to the rising cost-to-delivery ratios and poor
predictive value of existing in vitro tests (Maltman and
Przyborski 2010).
When engineering a tissue, recreating and control-
ling the overall cellular microenvironment is essential
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as this can strongly influence cell behaviour (Ozcelik
et al. 2014). The cellular microenvironment is made up
by factors that directly affect conditions around a cell
or a group of cells, which have direct or indirect effect
on cell behaviour via biophysical, biochemical or
alternate pathways (Ozcelik et al. 2014). There are
three main types of cues within the cellular microen-
vironment including biochemical, physiochemical and
mechano-structural as given in Table 1 (Sbrana and
Ahluwalia 2012). These can be controlled by using
in vitro design and engineering. Tissue constructs are
developed in a variety of forms utilising different
types of substrates, cell types and culture conditions to
suit a range of specific applications. Birnbaum
suggests a variety of components when combined
together can create a more biologically relevant 3D
tissue model compared to conventional 2D culture
models as given Table 2 (Birnbaum 2011). However,
due to technical challenges and complex interplay
between the components it can be difficult to produce
functional and mature tissue models incorporating all
features. The main components required for tissue
engineering include cells/tissues, scaffolds, bioreac-
tors and the ability to monitor the cellular environ-
ment. When choosing a bioreactor for cell culture it is
important to consider the scale of manufacture based
on whether the utility of the bioreactor is for research
or clinical purposes, which may require small or large-
scale batch sizes, respectively. Small-scale culture of
cells is typically used for in vitro research studies
based on micro and milli scale volumes. Large scale
culture for clinical use have been developed with
volumes of up to 20,000 litres (Harrison and Chauhan
2018). Some examples of large scale production for
clinical applications include adipose-derived stromal
cells for tissue engineering (Haack-Sørensen et al.
2018), human induced pluripotent stem cells for drug
screening regenerative medicine (Yamashita et al.
2018), megakaryocytic progenitor cell line for regen-
erative medicine (Retno Wahyu et al. 2018) and
mesenchymal stem cell for cartilage tissue generation
(Daly et al. 2018).
The extracellular matrix (ECM)
A major component of tissue volume is the extracel-
lular space, which contains a network of extracellular
matrix (ECM) proteins and polysaccharides that
surround the cells (Lberts et al. 2002). A schematic
showing the main constituents of the ECM are
displayed in Fig. 1. These include collagens, elastin,
fibronectin, laminins, glycoproteins, proteoglycans
and glycosaminoglycans, which are produced intra-
cellularly by resident cells and secreted by exocytosis
(Theocharis et al. 2016; Lewin et al. 2007).
Naturally occurring ECM provides inductive sig-
nals that may guide cell phenotype determination and/
or cell adhesion, proliferation, and survival (Neal et al.
2018). The requirement of cells to attach to the ECM
for cell growth is referred to as anchorage dependence,
which is mediated mainly by integrins and the
intracellular signals they generate. Integrins are
transmembrane receptors that facilitate interactions
between the ECM and the actin cytoskeleton during
cell motility and adhesion. Binding specificity is
regulated by the extracellular domain of integrins that
recognise ligands such as Arg-Glyc-Asp motif (RGD)
found on fibronectin (Chan et al. 2007). Electrospun
scaffolds have been used in tissue engineering to
mimic the structural framework of the extracellular
matrix to act as a template for cell growth. Their
fibrous porous structure can facilitate cell growth and
proliferation, creating more physiologically relevant
Table 1 The biochemical, physiochemical and mechano-
structural cues along with their factors present in the cellular
microenvironment
Cue Factors
Biochemical Cytokines
Other cells
Hormones
Nutrients
pH
Physio-chemical Oxygen
Temperature
Surface energy
Flow
Mechano-structural Shear stress
Strain
Stiffness
Roughness
Topography
Architecture
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3-Dimensional (3D) in vitro models, compared to
conventional 2D culture in well plates.
Tissue engineering
Tissue engineered systems can be described as three-
dimensional porous solid biomaterials (Dhandayutha-
pani et al. 2011) where cells can be seeded and the
Table 2 Generalised
components required to
make a 3-Dimensional
model to mimic in vivo
biological systems
Component Details
Scaffold Purified ECM, synthetic polymers, composites
Cells Stem/progenitor, differentiated, mixed cell types
Structure Porosity, topography, stiffness
Spatial/temporal patterning Cytokines gradients, controlled release
Perfusion Embedded channels, vascularisation
Bioreactors Optimised culture conditions, biomechanics
Innervation Signal propagation, coordinated response
Host response Generalised inflammation, specific immunity
Functional readout Real time, label free, non-destructive sensing, imaging
Computational framework Systems integration, multi-scale modelling, simulation, feedback
Fig. 1 Extracellular matrix extending outside the cell membrane, components include collagen, fibronectin, elastic, laminin and
proteoglycans
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scaffold construct will act as template for tissue
regeneration to guide the growth of new tissue
(Plunkett and O’Brien 2011). Decellularised extracel-
lular matrices are often referred to as the gold standard
of scaffolds. These are biological scaffolds derived
from native whole tissues that have had the cellular
components removed leaving behind micro and
macro-scale structural components and functional
ECM proteins. This provides the cues necessary for
cellular processes such as adhesion, proliferation and
maturation. However, challenges come with using
decellularised matrices including the sterilisation
process which should avoid damaging the ECM
ultrastructure and mechanical properties. In addition,
ECM scaffolds alone, and their degradation can induce
a host innate immune response (Taylor et al. 2018).
Scaffolds can be fabricated by a variety of methods
including electrospinning and 3D printing techniques
to create the morphology and dimensions to mimic the
native extracellular matrix (Harrington et al. 2014).
They also can be composed of natural polymers,
synthetic material or natural-synthetic material
hybrids. Natural polymers include purified extracel-
lular matrix proteins, which provide biological cues
for cell attachment and activity, whilst synthetic
polymers give the mechanical support required to
maintain the structural framework of the scaffold.
When designing the scaffold, parameters such as
porosity, topography and stiffness should also be
considered as these can affect cell behaviour, e.g.
cellular differentiation (Ghasemi-Mobarakeh 2015).
Scaffolds provide the necessary support for cells to
maintain viability, proliferate, and differentiate into
specific cells, and determine the morphology of the
resultant tissue. The attachment, proliferation and
differentiation of cells are strongly affected by the
microenvironment associated with a scaffold, includ-
ing the size, geometry, density of the pores, the
‘‘windows’’ connecting the pores and the surface
properties (Choi et al. 2010). Scaffolds can act as a
template of the extracellular matrix (ECM) to guide
cell attachment and tissue formation thus providing a
platform for structural support (Plunkett and O’Brien
2011).
The complexity of the network of ECM proteins
emphasises the importance of preparing a platform
that can mimic the structural features of the ECM to
facilitate cellular processes including cell adhesion,
proliferation and differentiation (Wang et al. 2013).
Scaffolds should be porous, to allow efficient nutrient
and oxygen diffusion to achieve high cell viability
without compromising the mechanical integrity of the
scaffold (Chan and Leong 2008). If the scaffold is
being used for implantation then the scaffold should
not induce a severe inflammatory response, as this
could reduce healing or cause rejection in the body.
Furthermore, scaffolds for implantation should be
biodegradable, as the aim is to support the body’s own
cells to produce their own ECM and replace the
implanted tissue engineered construct. Moreover, the
by-products of this degradation should be biocompat-
ible, so that it is nontoxic to the body, and
biodegradable.
The chosen scaffold biomaterial should have bio-
logical cues such as cell adhesive ligands to enhance
cell attachment or physical cues such as topography to
influence cell morphology and alignment (Chan and
Leong 2008). However, many scaffolds are fabricated
from synthetic polymers due to their mechanical
strength, so are often coated with natural based
polymers/ECM proteins. For example Li et al. coated
electrospun polycaprolactone fibres with gelatine
which improved biological activity compared to the
uncoated fibres (Li et al. 2008). Gelatine is effective at
enhancing cell adhesion because it contains abundant
Arg-Gly-Asp (RGD) sequences which are the cell
attachment sites recognised by many integrins. The
presence of RGD sequences therefore facilitates cell
adhesion and spreading (Xing et al. 2014). In addition,
Attia et al. (2011) coated synthetic polyurethane fibres
with a variety of ECM proteins including fibronectin,
collagen type I and vitronectin and found that
fibronectin demonstrated the greatest cell attachment,
and influenced cell spreading and alignment.
Fibronectin is a multifunctional glycoprotein pre-
sent in plasma in a soluble form and in the ECM. It is
expressed by many cell types and contributes to cell
adhesion, migration, proliferation and tissue develop-
ment (Attia et al. 2011). Some scaffolds can incorpo-
rate biomolecules such as growth factors, where the
scaffold serves as a delivery vehicle to the cells to
accelerate and enhance tissue regeneration (Chan and
Leong 2008). Growth factors are secreted by cells and
act as guidance signals for cell behaviour including
cell proliferation, migration, differentiation and tissue
regeneration (Zhang et al. 2016). Through utility of
encapsulation methods within scaffold fibres, biomo-
lecules with retained bioactivity can be released in a
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controlled manner (Chan and Leong 2008). However,
growth factors often have a short half-life and the
ability to deliver the growth factor specifically to the
cells can be a drawback during tissue regeneration
(Zhang et al. 2016). Some examples of growth factor
encapsulation within fibres includes a study by Wang
and Wang (2017). They fabricated electrospun nanofi-
brous scaffolds and incorporated growth factors
including recombinant human vein endothelial growth
factor which subsequently enhanced cell viability of
human umbilical vein endothelial cells. Zhang et al.
also prepared coaxial electrospun fibres with the
encapsulation of basic fibroblast growth factor (bFGF)
within the core of the fibres (Zhang et al. 2016). The
fibres were able to achieve controlled release of
growth factors with different rate and amounts.
Table 3 describes the functions of the native ECM
tissues and the features possessed by scaffolds to
recreate the biological and biomechanical cues of the
ECM.
Scaffold materials (synthetic vs natural polymers)
Scaffold materials can be composed of synthetic or
natural polymers which offer different properties such
as high porosity, tailored pore sizes, biodegradation,
mechanical strength dependent on their composition,
structure and arrangement of their constituent macro-
molecules (Dhandayuthapani et al. 2011). They are
easy to process and can easily incorporate bioactive
molecules to subsequently mimic the ECM structure.
Using synthetic and natural polymers as constructs for
tissue engineering has its advantages and disadvan-
tages as reviewed by Bhatia (Bhatia 2016). However,
synthetic polymers are more stable than natural
polymers and therefore have a longer shelf life, can
be readily sterilised, and are less temperature sensitive
than natural polymers. They are also more cost
effective than natural polymers, can be produced
under controlled conditions, and exhibit pre-
dictable and reproducible mechanical and physical
properties, such as tensile strength, elastic modules
and degradation rate. Examples of synthetic polymers
used for scaffolds include: poly (vinyl chloride),
poly(caprolactone), poly (lactic acid), poly (lactic-
co-glycolic acid) and poly (ethylene terephthalate).
Natural polymers are derived from living sources such
as the human body or animals. As natural derivatives,
they have bioactive properties, which allow them to
have better interactions with cells compared to
synthetic polymers (Dhandayuthapani et al. 2011) as
well as to enhanced biocompatibility and less toxicity.
Examples of natural polymers used for scaffolds
include gelatine, collagen, fibrinogen and elastin.
Scaffold fabrication techniques
There are a variety of approaches to fabricate scaffolds
for tissue engineering which should consider variables
such as biocompatibility, biodegradability,
Table 3 Summary of functions of the ECM in native tissues and how scaffolds in engineered tissues mimic the ECM
ECM in native tissues Scaffolds in engineered tissues
Provides structural support for cells to reside Porous, interconnected structure to support cell attachment, growth,
migration and differentiation
Contributes to the mechanical properties of the tissues Provides the shape and mechanical stability to the tissue defect and gives
the rigidity and stiffness to the engineered tissues
Provides bioactive cues for cells to respond to their
microenvironment
Can have binding sites such as RGD sequence and surface topography
which interacts with cells actively to facilitate activities such as
proliferation and differentiation
Acts as the reservoirs of growth factors and potentiates
their actions
Serves as a delivery vehicle and reservoir for applied growth factors
Provides a flexible physical environment to allow
remodelling in response to dynamic tissue processes
Provides a void volume for vascularisation and new tissue formation
during remodelling. Porous microstructure allows nutrients and
metabolites to diffuse. Degradation mechanisms and rates can be
controlled
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mechanical strength, pore size, scaffold architecture
and manufacturing technology (Plunkett and O’Brien
2011). Each approach has its own advantages and
disadvantages in preferred tissue engineering applica-
tions, whilst different types of cells prefer different
scaffold structures. The array of scaffold fabrication
techniques include: (1) solvent-casting and particu-
late-leaching (2) melt moulding, (3) freeze drying, (4)
thermally induced phase separation (5) gas foaming,
(6) electrospinning and (7) 3D printing.
Solvent-casting and particulate-leaching
Solvent-casting and particulate-leaching involves a
simple and cost-effective process of mixing a polymer
solution with salt particles of a specific diameter to
produce a porous scaffold. As shown in Fig. 2a, the
polymer is firstly dissolved in an organic solvent and
then poured into a mould containing a porogen such as
sodium chloride (Sampath et al. 2016). The solvent
then evaporates leaving behind a polymer matrix with
salt particles within. The construct is then immersed in
water where the salt particles leach to fabricate a
porous structure (Wosek 2015). An advantage to this
technique is that the pore size and overall porosity can
be tuned by changing the particle size (Annabi et al.
2010), which is fairly reproducible. Solvent
casted/particulate leached scaffolds can be used for
applications such as bone tissue engineering and have
been shown to support osteoblastic cell growth and
mineral deposition (Thadavirul et al. 2014). Con-
structs have been fabricated from polymers such as
Food and Drug Administration (FDA) approved
polycaprolactone which exhibits excellent biocom-
patibility and mechanical strength (Thadavirul et al.
2014). Highly porous scaffolds can be produced,
which is important for mass transport requirements for
cell nutrition, porous channels for cell migration and
surface features for cell attachment (Hollister 2005).
However, an increased porosity can compromise the
structural stability of the biomaterial, and therefore a
balance is needed between the mechanical and mass
transport function of the construct to create an optimal
scaffold system (Loh and Choong 2013). A drawback
of this method is that new tissue formation of often
limited to the surface of the construct with minimum
cell growth near the centre of necrotic zones in the
centre of the construct (Sopyan et al. 2008).
Furthermore solvent residues from the porogen or
solvent could be harmful/toxic to cells (Sopyan et al.
2008).
Melt moulding
Melt moulding can be used to create polymeric
scaffolds. The process involves filling moulds with a
powdered polymer, and porogen compounds above
the polymer’s glass transition temperature at an
elevated pressure (Janik and Marzec 2015). These
combine to form a scaffold in the shape of the mould.
The porogen is leached out by washing with water to
yield a porous polymer scaffold as shown in Fig. 2b.
The constructs exhibited high porosity and bone
formation within the scaffold for bone tissue engi-
neering applications. The advantages of this method
are that it is convenient, economical and does not
require toxic solvents. Furthermore, polymer scaffolds
can be rapidly produced of various shapes, sizes and
tailored pore size dependent on the porogen used
(Janik and Marzec 2015). The limitations of this
method involve difficulty in leaching out residual
porogens, which could affect tissue culture (Janik and
Marzec 2015). In addition, if incorporating bioactive
compounds into the construct, the high temperatures
used may destroy the molecules.
Freeze-drying
Freeze drying is a method used to make porous
materials for regenerative medicine applications
(Offeddu et al. 2015). Figure 2c shows the freeze-
drying process of a scaffold. The first stage of freeze-
drying involves cooling a polymer solution to a frozen
state. The solvent then forms ice crystals forcing the
polymer molecules to aggregate in between (Zhu and
Che 2013). The solvent is removed by reducing the
pressure and subliming the solvent. This leaves behind
a dry polymer scaffold with a highly porous intercon-
nected porous microstructure. Jin et al. (2015) fabri-
cated polycaprolactone/chitosan composite scaffolds
via freeze drying for bone regeneration applications.
An advantage to the freeze-dryingmethod is that water
can be used as the solvent instead of an organic solvent
which is more suitable for biomedical applications (Lu
et al. 2013). A disadvantage to this method is that,
although a highly porous construct can be fabricated, it
is more difficult to control the pore size.
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Fig. 2 a Solvent
casting/particulate leaching
process: The polymer is
dissolved in a solvent and
poured into a mould
containing a porogen. Upon
solvent evaporation the
polymer matrix with the
porogen remains. The
porogen is eliminated by
immersing in aqueous
media, thus producing a
porous structure. b Melt
Moulding: Moulds are filled
with a powdered polymer
and a porogen, pressure and
heat is applied. The porogen
is leached out by washing
with water to leave behind a
porous scaffold c Freeze-
drying: The polymer
solution is cooled to a frozen
state using liqud nitrogen.
The solvent forms ice
crystals causing the polymer
molecules to aggregate in
between. The solvent is
removed by sublimation of
the solvent and reduced
pressure, this leaves behind
a porous scaffold. d Thermal
induction phase separation:
Polymer powder is
dissolved in a solvent
mixture and heated. The
polymer solution is s cooled,
and phase separation takes
place due to the
thermodynamic instability.
The solvent is removed by
freeze drying leaving behind
a porous scaffold made up of
polymer-rich/poor phases
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Thermally induced phase separation
Phase separation is a thermodynamic process involv-
ing the separation of phases due to physical incom-
patibility to create scaffolds for tissue engineering
(Chen et al. 2013). As shown in Fig. 2d, the first step in
scaffold preparation is to make a uniform and homo-
geneous polymer solution. The polymer is dissolved in
a solvent and becomes thermodynamically unstable by
heating the mixture for a certain period and temper-
ature, in addition to subsequent cooling. The thermal
energy helps induce the phase separation separating
the solution into a polymer rich and polymer lean
phase (Akbarzadeh and Yousefi 2014). The solvent is
then removed by either freeze-drying or freeze-
extraction (Akbarzadeh and Yousefi 2014). The poly-
mer-rich phase will solidify to form a 3D matrix while
the polymer-poor phase will become the void space
(Chen et al. 2013). Yen et al. (2009) fabricated nano-
porous polycaprolactone scaffolds which demon-
strated controlled drug release for drug delivery
applications. In addition, Conoscenti et al. fabricated
highly porous, well defined pore sized poly(L-lactic
acid) scaffolds for bone engineering applications, and
demonstrated the scaffolds were able to support
chondrocyte differentiation (Conoscenti et al. 2017).
An advantage to this technique is that by easily
changing parameters such as polymer type, solvent/
non-solvent ratio, polymer concentration, heating
temperature and time, and cooling rate; porous
constructs can be fabricated with specific morpholo-
gies for a particular application (Akbarzadeh and
Yousefi 2014). Thermally induced phase separation is
a useful technique for developing scaffolds with well-
defined pore shape and pore size and can be combined
with other fabrication methods to control the final 3D
structure (Chen et al. 2013). However, the drawbacks
of this technique includes minimal control over fibre
orientation and diameter, long fabrication time, and
lack of mechanical properties.
Gas foaming
Gas foaming eliminates the use of harsh chemical
solvents by creating highly porous polymer scaffolds
by using high pressure carbon dioxide. Solid discs of a
polymer such as polyglycolide and poly-L-lactide are
first formed by compression moulding at high tem-
peratures (Loh and Choong 2013). High pressure
carbon dioxide (800 psi) is then applied to saturate the
polymer within an isolated chamber over a certain
period. Rapid depressurisation causes thermodynamic
instability and leads to form nucleated gas cells
creating pores inside the polymer matrix (Sampath
et al. 2016). Scaffolds sourced from poly(D,L-lactic-
co-glycolic acid)/nano-hydroxyapatite (PLGA/HA)
have been fabricated by this technique for bone tissue
engineering and have shown to exhibit efficient
osteoblast growth and activity for future bone regen-
eration applications (Kim et al. 2006). A disadvantage
to this technique is the inability to ensure pore
connectivity and control pore sizes by gas forming.
In addition high temperatures during disc formation
can inhibit the use of bioactive molecules in the
scaffolds (Loh and Choong 2013).
Electrospinning
Electrospinning is a simple technique compared to the
others due to the ability to easily control specific
parameters to fabricate a scaffold on the nano/micro
scale to mimic the fibrous structure of the native
extracellular matrix. Harrington et al. (2014) demon-
strated how an electrospun polymeric scaffolds can be
used to model decellularized lung extracellular matrix.
Electrospun scaffolds also offer a high surface area,
tuneable porosity, flexibility to cater to a different
sizes and shapes, and the ability to control the fibre
composition to achieve the specific properties or
functionality (Bhardwaj and Kundu 2010). The basic
electrospinning set up consists of a syringe pump,
polymer solution, needle, voltage supply and collect-
ing plate (Haider et al. 2015), as shown in Fig. 3b.
The electrospinning process is usually conducted at
room temperature and begins when a high voltage is
applied to the polymer solution and the polymer
droplet at the needle tip is held by surface tension. At a
critical voltage the surface tension of the liquid is
overcome causing the droplet to elongate into a Taylor
Cone. A continuous fine fibre jet is ejected from the tip
of the Taylor Cone and is accelerated towards the
oppositely charged grounded collecting plate. As the
fibre travels through the air the solvent evaporates and
solid polymer fibres are deposited on grounded
collector as a scaffold (Haider et al. 2015; Pillay
et al. 2013). Although electrospinning appears to be a
simple process, a disadvantage to this technique is that
several parameters can affect the fibre morphology
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and need to be optimised to produce smooth uniform
fibres such as: voltage, flow rate, polymer concentra-
tion, solvent, relative humidity, distance from the
needle tip to the collecting plate, and temperature.
Without the optimal conditions, fibres produced may
be too thick or thin, or can become beaded leading to a
non-uniform structure or may not spin at all.
Electrospinning is a versatile technique and has
been used for many tissue engineering applications,
including (1) skin tissue, using poly(lactic-co-glycolic
acid) (PLGA) scaffolds (Ru et al. 2015), (2) bone
tissue using polycaprolactone (PCL), PLLA, silk, and
collagen (Khajavi et al. 2016), (3) corneal tissue, using
poly-L-lactic acid (PLLA) PCL, PLGA, gelatine, silk,
and collagen (Kong and Mi 2016), (4) cardiac tissue
using PLGA scaffolds (P Prabhakaran et al. 2011), (5)
drug delivery (Mirjalili and Zohoori 2016) (6) wound
healing (Askari et al. 2016)and (7) detection of metal
ions (Kim et al. 2017).
3D printing
3D printing uses an inkjet printing liquid binder to
make a 3D object from digital model data shown in
Fig. 3 a Gas foaming: The polymer is firstly compressed and
moulded at a high temperature. The polymer is placed inside a
gas foaming reactor and exposed to high pressure carbon
dioxide to saturate the polymer. Rapid depressurisation leads to
the formation of nucleated gas cells creating pores in the
polymer scaffold. c 3D printing: Uses computer aided design to
create a digital template to print. A thin layer of powder is placed
on the powder bed and spread using a rolling mechanism. The
printing machine reads the design of the template and the inkjet
nozzle selectively lays down the binder solution into a powder
bed. The layering is repeated to create a 3D model. The excess
unbound powder is removed leaving behind the construct.
b Electrospinning: A polymer is dissolved in a solvent and the
polymer solution is placed in a syringe onto a syringe pump. A
voltage is applied to the polymer solution the tip of the polymer
drop at the end of the needle is stretched into a Taylor cone. This
then becomes unstable and produces a polymer jet which is
attracted to the oppositely charged collecting plate
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Fig. 3c. The first step of 3D printing involves mod-
elling a virtual model using computer-aided design
where the machine uses this as a template to print
(Sampath et al. 2016). A thin layer of powder is
deposited onto a powder bed and is spread and levelled
onto a building platform using a roller system (Do
et al. 2015). The machine reads the design of the
digital model data and a printer nozzle selectively lays
down liquid binder solution into a powder bed to form
a 2D pattern (Sampath et al. 2016). This process is
repeated layer by layer to produce a 3D model. Once
the binder solution and powder are combined the
excess unbound powder is removed (Do et al. 2015).
Sun et al. (2016) fabricated highly porous collagen/
silk constructs using 3D printing for applications in
bone tissue engineering. They found that bone mes-
enchymal stem cells were able to maintain their
viability, proliferate and deposit ECM proteins effi-
ciently. In addition, the 3D printing technology was
found to be simple, easy to operate, was fast at printing
and can print and assemble bioactive tissue. However,
attention needs to be paid when selecting the compo-
sition ratio of the material for printing as unsuit-
able proportions or incompatible materials can result
in interference with the spray nozzle or block the print
head resulting in unstable three-dimensional scaffolds
and poor performance (Sun et al. 2016). The main
advantages of 3D printing include the ability to
fabricate versatile scaffolds with complex shapes and
the ability to imitate the extracellular matrix (Do et al.
2015). However, this can be limited by the use of
printable materials that have the stability and desired
properties for 3D printing, often alternative material
methods processing methods are required to work with
materials not easily printed (Chia and Wu 2015).
Furthermore, incorporating bioactive molecules can
be a challenge as they may be sensitive to the printing
environment (Wu and Hsu 2015); particularly if the
printing processes involve a solvent or extreme
temperature the proteins folding may be affected, or
they can be denatured (Wu and Hsu 2015). Production
time for scaffold fabrication can become lengthy as the
scaffold design becomes more precise and intricate
(Do et al. 2015). Other methods of 3D printing
reviewed by Mota et al. (de Azevedo Gonc¸alves Mota
et al. 2016) include selective laser sintering, stere-
olithography, fused filament fabrication,solvent cast-
ing 3D printing and more recently, digital light
processing (Du¨regger et al. 2018).
Bioreactors
Bioreactors complement the use of scaffolds in tissue
engineering, and can be described as devices that
utilise mechanical methods to influence biological
processes (Plunkett and O’Brien 2011). Cell-seeded
porous scaffolds have been placed in a range of
different bioreactors including (1) orbital shakers, (2)
spinner flasks, (3) rotating wall vessels, (4) perfusion
bioreactors and (5) microfluidic devices, to aid the
production of functional 3D tissues. The key features
for an ideal bioreactor system are given in Table 4.
They maintain a desired uniform cell concentration
within the scaffold during cell seeding (Salehi-nik
et al. 2015) which facilitates adequate cell–cell
interactions (Kumar 2016). Exposure to medium fluid
flow can be used to mimic physiologic delivery of
oxygen, nutrient supply, chemical signals and contin-
uous waste removal from 3-D tissue engineered
constructs and has been shown to provide significantly
higher mass transfer rates compared to static cultures
(Rangarajan et al. 2014). The fluid shear stress caused
by mixing or perfusion of culture medium will expose
cells to mechanical stimulation (Gaspar et al. 2012)
that can mimic stimulants such as interstitial flow
which can affect cellular alignment and differentiation
(Ng and Swartz 2006). Bioreactors have also been
shown to enhance the rate of proliferation and reduce
necrotic core formation in scaffolds. compared to
static cultures (Khang 2017). Bioreactors are limited
by the lack of specific guidelines available in terms of
which flow rate/speed to use or volume of culture
medium, as different cells have different cell culture
requirements (Ismadi et al. 2014). Many bioreactor
systems also do not incorporate the ability to non-
invasively monitor the microenvironment in real time,
which means important parameters such as oxygen,
pH, temperature cannot be controlled. Bioreactor
systems should be chosen based on their specific
application, some of which permit turbulent or laminar
flow, others are more suited for suspension cultures or
adherent cell types, and some bioreactors are neces-
sary for larger scale culture.
Spinner flask
The spinner-flask bioreactor was developed to create a
convective flow and produce hydrodynamic forces
that help mass transport throughout cell seeded
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scaffolds (Gaspar et al. 2012). Spinner flasks consist of
a cylindrical glass container in which growing tissues
are suspended and a stirring element such as a
magnetic stirrer is placed at the bottom of the tank
ensuring the mixing of the culture medium (Sucosky
et al. 2004). The scaffolds are in fixed positions,
threaded in needles attached to the cap of the container
(Gaspar et al. 2012), shown in Fig. 4a. The mixing
mechanism of this bioreactor has been shown to
improve cellular distribution and differentiation in
scaffolds (Stiehler et al. 2009). Spinner flasks are
commonly used for bone tissue engineering as they
can mimic some aspects of the native bone environ-
ment. However, spinner flasks are thought to only
permit the extracellular matrix production at the
scaffolds surface and mixing the media can create
turbulent shear at the surfaces which can be unfavour-
able to cell growth and tissue formation (Gaspar et al.
2012).
Spinner flasks can be set up in batch and continuous
cultures. Batch mode is a closed type of cultivation
system that does not allow for the addition of fresh
medium or the removal of waste, this can limit the
product yield, whilst overcoming the risks of contam-
ination. This method is also limited both in scale and
length of culture due to a build-up of metabolites and
waste that occurs over time. Continuous cultures allow
the removal of waste, but this exposes the culture to a
maximum chance of contamination. Fed-batch is an
intermediate and is a semi closed type, it allows the
addition of fresh nutrition but no removal of waste
which produces a medium yield.
Rotating wall vessel
Rotating wall vessels consist of cylindrical bioreactors
which are filled with culture medium and rotated along
a horizontal axis as shown in Fig. 4b. The physiolog-
ical low fluid shear stress environment is usually used
for suspension cultures, where the cells can aggregate
based on their natural cellular natural cellular affini-
ties, form 3-D structures and acquire properties of
highly differentiated cells (Skardal et al. 2010).
Studies have been performed to investigate the effects
on dynamic flow in a 3D environment on bone cell
biology and bone formation in vitro. Adherent cell
lines can be cultured on scaffolds, however these can
experience repeated collisions with the bioreactor wall
which has been shown to limit achievable cell density
(Yu et al. 2004).
Perfusion bioreactors
Perfusion bioreactors are used to provide a flow of
medium through or over a cell population, in order to
help push the oxygen and nutrients through the pores
of 3D scaffolds (Salehi-nik et al. 2015). Different
types of perfusion bioreactors are available, some of
which are commercially available whilst others are
produced in-house for various types of applications.
Figure 4c shows a standard set up of a perfusion
bioreactor system. Perfusion bioreactors are very
versatile and generally can be set up in different
configurations, including a closed set up where the
media recirculates to provide media containing natu-
rally produced growth factors, or single pass set up
Table 4 Key features required for an ideal bioreactor system
Features Description
Leak proof Reduces risk of contamination, and loss of reagents
Optically transparent Allows in situ real time monitoring
Easy to assemble Less training required, rapid experimental set-up
Ability to monitor microenvironment Provide data on culture conditions such as pH, oxygen, carbon dioxide, metabolites
Allows use of different flow types/rates Different flow rates/types are required for different cell types/applications
Allows easy insertion and retrieval of scaffolds Allows 3D cell culture and post analysis.
High throughput Quicker data acquisition
Flexible configuration Modular interconnected systems allow co-culture and cell–cell signalling
No air bubble formation Presence of air bubbles can disrupt the flow rate and disturb cells
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where only fresh media is supplied to the cells
avoiding the accumulation of metabolites. Flow rates
should be optimised when setting up perfusion biore-
actor systems, as cells can be damaged at high flow
rates, or may not have sufficient nutrient and oxygen
supply at low flow rates. Flow can be used to deliver
shear stress such as unidirectional laminar, pulsatile
laminar, turbulent and oscillating flow. Perfusion
bioreactors have been used to provide shear stress to
induce human mesenchymal stem cells (Lembong
et al. 2018; Bhaskar et al. 2017), cardiovascular
engineering (van Haaften et al. 2018),
Fig. 4 a Spinner flask: Scaffolds are threaded through needles
within a glass container. A magnetic stirrer is used to stir the
medium throughout the construct. b Rotating wall vessel:
Scaffold constructs are placed in a cylindrical bioreactor filled
with medium. The bioreactor is rotated along the horizontal axis
to stir the medium c Perfusion bioreactors: Medium is pumped
around a circuit by a peristaltic pump. The media passes through
the bioreactor containing the scaffold construct. The set up can
be recirculating or single pass
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Quasi-Vivo
The Quasi Vivo (QV) is a perfusion bioreactor
system commercially available in different formats
and configurations. ‘‘Quasi’’ is derived from the Latin
definition of ‘resembling, but not actual’, and ‘‘vivo’’
from the same derivation meaning ‘living thing’,
together the name represents a system that can create
conditions that are very similar to physiologically
relevant conditions in living organisms.
There are a variety of different QV bioreactor
systems to suit different tissues and applications
including QV500, QV600 and QV900 shown in
Fig. 5. Some of the advantages of the QV systems is
that all of the systems can be set up to either provide a
single flow of fresh medium, or recirculating medium
which removes the risk of shock or disturbance to the
cells during feeding (Przyborski 2017). In addition,
recirculating media enables the production of condi-
tioned media containing a cocktail of growth factors
and cytokines. All of the chambers can accommodate
an adjustable laminar flow rate and chamber pressure
to suit the specific requirements of different tissue
types (Przyborski 2017). The Quasi Vivo systems are
known for their simplicity, ease of use, and variety of
published studies showing the enhanced cell activity
using these bioreactors. The ability to easily insert/
retrieve scaffolds from the bioreactor is useful for post
analysis i.e. immunohistochemistry. The QV systems
all have a flexible modular configuration, the individ-
ual bioreactors can be interconnected to allowmultiple
or the same cells types to be cultured in separate
chambers. This can enable cross talk between the
tissues which is important when recreating specific
organ interactions.
QV500 applications include cardiovascular stem
cell differentiation (Pagliari et al. 2014), fluid shear
stress on hepatocytes (Rashidi et al. 2016), a inter-
connected blood brain barrier model (Miranda-Azpi-
azu et al. 2018) and nanotoxicity with endothelial cells
Fig. 5 a Photographs of
showing the slight
difference in structure of the
original McmB and the
patented Quasi Vivo
chamber (i) McmB (ii)
Quasi Vivo500. b Quasi
Vivo500 chamber for
submerged cultures. c Quasi
Vivo600 chamber,
compatible with
commercially available
Transwells for air liquid
interface applicattions, and
also Millipore standing
inserts when secured by an
‘O’ ring for liquid–liquid
barrier applications. d Quasi
Vivo900 for submerged
cultures. The chambers have
an optically transparent
window at the base of the
chamber to allow live cell
imaging, and the trays are
made of acrylic to help
reduce non-specific binding
of compounds. e Quasi
Vivo system with
reservoir, tubing and
bioreactor
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(Ucciferri et al. 2014). The QV600 has been used for
the preparation of lung models, where it has been has
shown accelerated proliferation of epithelial cells
(Chandorkar et al. 2017), as well as gastrointestinal
tract and blood brain barrier models. The most
recently developed QV900 consists of multiple opti-
cally transparent bioreactors integrated into a multi-
well tray that enhance monitoring of parameters
though microscopy, Fig. 5d. The QV900 is fabricated
from acrylic to reduce non-specific binding of
molecules and compounds for drug development
applications. (Stosik et al. 2018) recently used the
system for drug exposure, comparing the CYP activity
in primary human hepaotcytes in flow conditions vs
static. Nithiananthan et al. used the QV900 to inves-
tigate the effect interstitial fluid flow on fibroblast
response (Nithiananthan et al. 2016).
Microfluidics
Perfusion bioreactors can also come in the form of
microfluidic devices to miniaturise macroscopic sys-
tems for higher throughput of biological experiments.
In addition, they enable studies of cell behaviour of
organisms with precise and localised application of
experimental conditions which are difficult to achieve
using macroscopic tools (Velve-Casquillas et al.
2010). Microfluidic devices include organ-on-chips
where specific cell types are cultured and continuously
perfused within micrometre-sized chambers to model
physiological functions of a particular tissue or organ
(Bhatia and Ingber 2014).
Devices are often fabricated from PDMS using
rapid, simple, and inexpensive techniques such as soft
lithography, which involves the replication of a
topographically defined structure on a master in a soft
elastomer (Tang andWhitesides 2010). The designs of
microfluidic devices are very flexible and can there-
fore cater to for variety applications, however each
device is highly specific to single experimental
configurations. Due to the very small nature of the
platform, only a low number of cells and reagents are
required which is more cost efficient. Live cell
imaging and real time on chip analysis can be
performed with direct coupling to down-stream anal-
ysis systems (Halldorsson et al. 2015).
Some of the drawbacks of the microfluidic devices
include the non-standard culture protocols entail
complex operational control and chip design. In
addition, the reduction in scaling can provide chal-
lenges in adapting biological protocols to fit experi-
ments based in a microsystem, such as the media and
cell concentration (Velve-Casquillas et al. 2010).
Small working volumes for seeding and reagents can
also be challenging for subsequent analytical chem-
istry, complex operational control and chip design
(Halldorsson et al. 2015). Furthermore, many in vitro
models now push the use of scaffolds to create the
native microenvironment, however loading and
retrieving scaffolds from the microfluidic devices
can be difficult, and even when inserted the scaffold
area would be very small. Dongeun Huh describes the
fabrication of a PDMSmicrofluidic device to replicate
the microarchitecture and dynamic microenvironment
of the alveolar–capillary unit of the living human lung
(Huh 2015). A variety of commercially available
perfusion bioreactors are available for different appli-
cations and come with their own advantages and
limitations.
Future outlook
Monitoring of culture conditions and tissue
constructs
Many complex in vitro models have been developed
for specific tissue engineering and regenerative
medicine applications. However, one of the challenges
is continuous monitoring of cellular activities within
3D, generally opaque thick structures (Ozcelik et al.
2014). Many of the developed in vitro models are
limited by the ability to monitor cell culture conditions
in a non-invasive manner. With the lack of ability to
monitor the tissue regeneration processes in situ, it can
limit our understanding of optimal conditions required
for growth (Harrington et al. 2013). Therefore, novel
techniques for monitoring in vitro cultures at all stages
of tissue growth, repair and regeneration in a more
insightful, non-invasive and quantitative manner is
imperative (Papantoniou et al. 2014; Kotecha et al.
2013).
With non-invasive in situ monitoring in real time
we can monitor cell growth, cellular differentiation
and tissue morphogenesis (Kotecha et al. 2013), and
develop more reliable tissue engineered constructs
that are more physiologically relevant models for
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disease and drug testing. Moreover, non-invasive
monitoring can provide real time functional read outs,
without having to disturb the cellular microenviron-
ment or introduce potential contamination. Currently
widely used methods of monitoring tissue engineered
constructs include destructive end point determination
and biochemical or histological methods to determine
cell number, viability and tissue growth throughout the
construct (Papantoniou et al. 2014). Therefore simple
and readily applicable non-destructive methods of
monitoring changes in cell metabolism, viability and
tissue deposition particularly within long term cultures
would be invaluable and could point out adverse
responses during the early stages of culture (Boubriak
et al. 2006).
Biosensors
Biosensors can be used for direct real-time monitoring
of processes within engineered tissues (Ozcelik et al.
2014). Biosensors can be defined as ‘‘a self-contained
analytical device that combines a biological compo-
nent with a physicochemical component for the
detection of an analyte of biological importance’’
(Hasan et al. 2014). By detecting cellular analytes,
electrical activity, physical and chemical signals
transmitted by cells, biosensors can provide insights
into cellular activities and responses in real time
(Perestrelo et al. 2015). When designing robust
biosensors they should meet several requirements
such as being able to detect trace amounts of
biomarkers within complex biological environments
such as cell culture medium, which usually contains a
plethora of nonspecific proteins and interfering com-
pounds (Shin et al. 2017). In addition, the robust
biosensor systems should be able to have continual
monitoring capability every few hours or days for
kinetics analysis of biomarkers over extended periods
(Shin et al. 2017). Biosensors are made up of three
main components, 1) a detector to detect the stimulus,
2) a transducer to convert the stimulus to output signal,
3) a signal processing system to process the output and
present it in an appropriate form (Hasan et al. 2014).
Hasan et al. (2014) reviews the different kind of
biosensors and its components. The sensing compo-
nent or bioreceptor includes enzymes, microbes, cells,
nucleic acids, and antibodies. The different types of
transducers are listed in Tables 5 and 6. The
applications of biosensors include sensing small
molecules such as glucose, hydrogen peroxide,
adenosines, functional protein molecules, pathogenic
microbes.
Electrochemical biosensors
Electrochemical sensors operate by reacting with an
analyte of interest to produce an electrical signal
proportional to the analyte concentration (Hammond
et al. 2016). Different types of electrochemical
biosensors measurements include potentiometric,
amperometric and conductometric which can detect
a variety of analytes, see Tables 5 and 6. One of the
key advantages of electrochemical biosensors is their
simplicity. Inexpensive electrodes can be easily inte-
grated with simple electronics to perform rapid
measurements in miniaturised easy-to-use
portable systems. Miniaturisation is important because
biological samples are often available in small
amounts, and tissue damage must be minimised in
cases of in vivo monitoring (Sa˘ndulescu et al. 2015).
Being able to determine the concentration of an
analyte within a complex sample at the point-of-care
and in near real time with short response times is
extremely attractive for medical diagnosis, monitoring
of existing conditions and environmental monitoring
(Hammond et al. 2016). The different types of
electrochemical biosensor measurements have been
reviewed by Stradiotto et al. (2003).
The most widely used potentiometric device is the
pH electrode due to its simplicity, rapidity, low cost,
applicability to a wide concentration range and
particularly to its extremely high selectivity for
hydrogen ions. Glass electrodes are composed of a
thin ion-sensitive glass membrane and can monitor
cations including sodium, lithium, ammonium and
potassium (Stradiotto et al. 2003). Disadvantages to
using pH electrodes are that they are bulky and
invasive for tissue engineering applications, they
require frequent recalibration, the glass tip can be
easily damaged should always be kept wet to prevent
dehydration of the hydrated glass gel layer on the
external surface of the electrode.
The ion selective electrode is an example of an
electrochemical biosensor and consists of an indicator
electrode capable of selectively measuring specific
ions. They are generally composed of a working
electrode (potential is determined by its environment)
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and a reference electrode (potential fixed by a solution
containing ion of interest at a constant activity)
(Stradiotto et al. 2003). Since the potential of the
reference electrode is constant, the value of the
potential difference (cell potential) can be related to
the concentration of the dissolved ion (Stradiotto et al.
2003). Amperometric biosensors have been widely
used in point-of-care testing for applications such as
monitoring glucose levels in people with diabetes
(Hammond et al. 2016). Amperometric biosensors
function by the production of a current when a
potential is applied between two electrodes (Chaplin
2014). Some of the drawbacks of amperometric
sensors are electrochemical interferences (detection
of non-specific analytes), the lack or low response
reproducibility, particularly since sensing biocompo-
nents often have a limited lifetime. In addition,
modifying the electrode surface to favour a single
electrochemical process can be a difficult task. In
addition, in the case of in vivo measurements
biocompatibility and biofouling can be critical issues
(Sa˘ndulescu et al. 2015). Conductometric sensors rely
on changes of electric.conductivity of a film or a bulk
material, whose conductivity is affected by the analyte
present (Stradiotto et al. 2003). Thin films are used
mostly as gas sensors, due to their conductivity
changes following surface chemisorption (Stradiotto
et al. 2003).
Table 5 Different types of transducers and the measured property for tissue engineering applications
Type of
transducers
Measured property Compatible
with
bioreactor?
Example/reference
Electrochemical Potentiometric, Amperometric,
Conductometric, Nanotechnology,
Bioelectronics
Yes Electrochemical immunosensors integrated into
bioreactors for continual monitoring of cell secreted
biomarkers Riahi et al. (2016)
Protein Immunosensor Yes Glucose monitoring in living cells using single
fluorescent protein-based sensors Hu et al. (2018)
Electrical Surface conductivity, Electrolyte
conductivity
Yes Electrical Impedance Spectroscopy cell monitoring in a
miniaturised bioreactor
Martı´nez-Teruel et al. (2013)
Optical Fluorescence, Adsorption &
Reflection
Yes Low-cost calibration-free pH sensing with
disposable optical sensors (Ge et al. 2012)
Light Bioluminescence Yes Real-Time Bioluminescence Imaging of Cell
Distribution, Growth, and Differentiation in a Three-
Dimensional Scaffold Under Interstitial Perfusion for
Tissue Engineering Vila et al. (2016)
Table 6 Different types of biosensors
Measurement type Transducer Transducer analyte
Potentiometric Ion-selective electrode K?, Cl-, Ca2?, F-,
Glass electrode H?, Na?,
Gas electrode CO2, NH3,
Metal electrode Redox species
Amperometric Metal or carbon electrode O2, sugars, alcohols,
Chemically modified electrodes Sugars, alcohols, phenols, oligonucleotides
Conductometric Interdigitated electrodes Urea, charged species, oligonucleotides
Metal electrode
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Optical biosensors
Optical biosensors are one of the most common type of
biosensor used for applications such as environmental
monitoring, food safety, drug development, biomed-
ical research, and diagnosis (Long et al. 2013). The
main goal of optical biosensors is to produce a signal
which is proportionate to the concentration of an
analyte (Damborsky et al. 2016). Optical biosensors
that exploit light absorption, fluorescence, lumines-
cence, refractive index, Raman scattering and reflec-
tance are powerful alternatives to conventional
analytical techniques (Long et al. 2013) They allow
rapid, highly sensitive, highly specific, real-time, cost
effective detection of biological and chemical sub-
stances without any time-consuming sample concen-
tration or prior sample pre-treatment steps. Figure 6
shows a schematic of a biosensor which displays the
first stage as the target of interest, these are identified
by biorecognition molecules, an optical transducer
converts the signal into another signal form which can
be amplified and analysed. Optical biosensors can be
split into two main categories including label-free and
label-based.
Label-free detection involves the generation of a
signal directly by the interaction of the analysed
material with the transducer. Whereas label-based
involves the use of a label and the optical signal is then
generated by a colorimetric, fluorescent or lumines-
cent method. For example, glucose can be detected by
enzymatic oxidation using label-assisted sensing.
Jankowska et al. developed a biosensor based system
to monitor pH and glucose concentration during
wound healing (Jankowska et al. 2017). The hydrogel
coating composed of a fluorescent pH indicator dye
and a metabolite-sensing enzymatic system, based on
glucose oxidase and horseradish peroxidase. Changes
in metabolite and enzyme concentration in artificial
wound extract were successfully converted into a
fluorescent signal.
Fluorescence probes for monitoring
Fluorescent probes can also be used to monitor the
cellular microenvironment. This can be achieved by
fluorescently labelling proteins of interest, delivering
fluorescent nanoparticles, incorporating fluorescent
protein tags and live cell dyes to investigate cellular
processes under the microscope (Ettinger and Witt-
mann 2014).
Fluorescent proteins
As mentioned, fluorescence monitoring can be per-
formed in tissue engineering and regenerative medi-
cine by fluorescently labelling proteins of interest.
Some proteins or small molecules in cells are naturally
fluorescent; which is known as intrinsic fluorescence
or auto fluorescence and can be used to label live cells
for monitoring (Jensen 2013). The chemically inert,
green fluorescent protein (GFP) is an example com-
mon naturally occurring fluorescent protein sourced
from jelly fish Aquorea Victoria (Tian et al. 1999).
Upon excitation of UV or blue light, the GFP emits a
bright green light. By creation of a genetic in-frame
fusion of the fluorescent protein to a protein of interest,
localisation of that protein to specific tissues, cells or
subcellular compartments can be monitored and
imaged non-invasively (Jensen 2013).
Fig. 6 Optical biosensors are designed to target a molecule. Optical biosensors have biorecognition molecules specific to the target
molecule, the signal is then optically transduced, and the signal is processed
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Fluorescent proteins can act as reporters by fusing
the reporter gene to the promoter or coding sequence
of a gene of interest, this will provide information on
how much the gene or protein is expressed (Noguchi
and Golden). Fluorescent proteins have many advan-
tages and disadvantages as reviewed by Noguchi and
Golden (Noguchi and Golden) and Jensen (2013). (1)
They have a very bright fluorescent signal which is
useful for visualisation of specific structures within
cells (Noguchi and Golden). However, on the other
hand the brightness emitted can be affected by
temperature and can vary depending on the cell type
(Jensen 2013). (2) The fluorescent proteins come in a
variety of colours which can be fused to different
proteins of interest within the same cell to study the
co-localisation and expression of multiple proteins
simultaneously (Noguchi and Golden). But care
should be taken when selecting particular fluorescent
proteins for cells, as for example Ds-Red fluorescent
protein impairs the viability or growth of hematopoi-
etic stem and progenitor cells (Jensen 2013). (3)
Specific areas in a small area of tissue or cells can be
excited by using confocal microscopy, which can also
generate 2-D or 3-D images (Noguchi and Golden).
Disadvantages to using fluorescent proteins are: (1)
Prolonged exposure to excitation light can generate
free radicals (reactive oxygen species) which can
damage DNA, RNA and proteins by oxidation,
resulting in phototoxicity. (2) Moreover, it has also
been shown that fluorescent proteins can induce
apoptosis in cells, which indicates a possible reason
for the difficulty in establishing stable cell lines
expressing the protein. (3) Attaching a fluorescent
protein to a protein of interest generally does not affect
function, structure, and localization of a protein.
However, in some cases, it can impair protein function
and expression of this construct can adversely affect
cellular function. (4) Prolonged exposure to excitation
light causes photobleaching of fluorescent proteins
which reduces their ability to fluoresce. (5) Cells
contain compounds that exhibit auto fluorescence,
therefore the signal from the fluorescent proteins need
to be high enough compared to the auto fluorescence to
rise above the background.
Fluorescent nanosensors
Fluorescent nanosensors are sub-micron sized optical
sensors specifically designed for non-invasive analyte
monitoring in real time (Desai et al. 2014). They
generally based on porous matrices composed of
crosslinked polyacrylamide which encapsulate a sens-
ing component that is responsive to analytes (Buck
et al. 2004). such as hydrogen ions (Chauhan et al.
2011), calcium ions (Di Si et al. 2012), magnesium
ions (Park et al. 2003), temperature (Chauhan et al.
2014), reactive oxygen species (Lavado et al. 2015),
molecular oxygen (Chauhan et al. 2016; Giuntini et al.
2014) and glucose (Xu et al. 2002). Firstly, by
encapsulating the sensing component such as an
synthetic organic fluorophore, the matrix provides a
protective coating which prevents interferences such
as non-specific protein binding within a cell and
protects the cell from potentially toxic effects of free
fluorophores (Buck et al. 2004). Ratiometric fluores-
cent nanosensors have been developed which are
composed of a fluorescent indicator dye, and a
reference dye encapsulated within the matrix. The
sensor response is based on the fluorescence emission
intensity ration between the indicator dye and the
unresponsive reference dye to the target analyte. By
using a ratio a more accurate measurement of the
analyte can be achieved (Buck et al. 2004). Since the
production of fluorescent nanosensors, a number of
ratiometric fluorescence nanosensors for pH (Chauhan
et al. 2013; Orsi et al. 2015; Elsutohy et al. 2017) have
been reported based on polymeric nanoparticles, silica
nanoparticles, quantum dots, cellulose nanocrystals,
latex nanobeads, and zeolite-based nanoparticles
(Marı´n et al. 2012). Overall, fluorescent nanosensors
are useful for sensing due to their small size, fast
response, intense signal, against relatively low back-
ground noise, relatively simple instrumental set-up,
and ability to monitor non-invasively (Harrison and
Chauhan 2018).
Quantum dots
Quantum dots (Qdots) are semi-conductor nanoparti-
cles of a narrow size between (5–10 nm in diameter)
and emit light if electricity or light is applied to them
(Hasan et al. 2014). They are very photostable, with a
long fluorescence life time and their fluorescence can
be controlled by their size, for example larger dots
may emit a red fluorescence, whereas smaller dots
emit a green fluorescence. Quantum dots generally
consist of a three layer-structure, composed of a core,
shell and polymer coating. The most common
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quantum dots have a cadmium chalcogenide core
which is usually coated with a zinc sulphide shell to
improve photoluminescence. The outer surface of the
quantum dot is usually modified so the dots can be
directed to a target. The application of quantum dots is
similar to the use of organic fluorophores and can be
used for specific labelling of individual cell surface
biomolecules. Jensen reviews the limitations of quan-
tum dots. One of the major limitations is the toxicity of
the quantum dots (Jensen 2013). This is due to the
semiconductor material which are usually heavy
metals embedded within the core, and the generation
of free radicals during excitation. Since they are
composed of heavy metals they are potentially toxic
during in vitro imaging. Another issue is that quantum
dots sometes have specialised coatings which make
the overall molecule much larger than small organic
dyes. This is more of an issue for cell internalisation
and subsequent intracellular tracking. Since the fluo-
rescence intensity of Qdots is highly stable and
sensitive, fluorescence transduction based on chemical
or physical interaction occurs on the surface either
through direct photoluminescent activation or through
quenching. Qdots have been widely investigated for
possibilities of sensing pH, ions, organic compounds,
and biomolecules (nucleic acids, protein, and
enzymes), as well as other molecules of biological
interest. While the toxic effects of some Qdots have
still remained as a concern, the recent advancements in
application of Qdots in tissue engineering to detect the
enzyme and biomolecules are significant achieve-
ments of biosensing research (Hasan et al. 2014).
Monitoring in bioreactors and microfluidics
As mentioned, a bioreactor is a vessel that allows
biological/chemical reactions or processes to occur,
which can be on an industrial scale. Bioreactors have
been commonly used for applications such as fermen-
tation for the production of ethanol (Roy et al. 2016),
production of therapeutic proteins (Timm et al. 2015),
viral vaccine production(Gallo–Ramı´rez et al. 2015).
Being able to monitor parameters that affect biotech-
nological processes is important to ensure productivity
and product quality (Reinecke et al. 2015). Parameters
that should be monitored include temperature, pH,
glucose, pO2, PCO2, and cell density within the culture
medium (Reinecke et al. 2015). Bioreactor monitoring
techniques can be placed in three main categories,
including offline, inline and online (Lourenc¸o et al.
2012). Offline measurements include manual or auto-
matic sampling, transferring of a sample to a separate
laboratory to be analysed, which often causes a delay
in the analysis. Inline monitoring also includes manual
or automatic sampling; however, the collected sam-
ples are analysed within close vicinity of the bioreac-
tor. Online monitoring includes in situ measurement
acquisition, where the sensing device is often incor-
porated into the bioreactor and the sample is typically
not removed. The chemical components within biore-
actor media are mainly monitored by offline methods
that require a biomass separation step, such as high-
performance liquid chromatography. However these
methods can be time consuming and do not enable real
time knowledge of the conditions affecting bioprocess
performance (Lourenc¸o et al. 2012). Tables 5 and 6
provides an overview of examples of where different
kinds of transducers have been incorporated into
biosensors.
Many microfluidic devices used for organ mod-
elling have more recently began incorporating the
ability to monitor the cellular environment. Being able
to monitor the chemical environment can help
improve understanding of cellular responses (Acosta
et al. 2007). Oxygen is often a key component that is
monitored within microfluidic devices. This is because
oxygen is required for aerobic respiration and impacts
cell viability, in addition oxygen tension can impact
cell migration (Acosta et al. 2007). Being able to
monitor oxygen levels in microfluidic devices is
difficult, as conventional methods of oxygen sensing
include the use of bulky probes. Compared with
electrochemical methods, optical oxygen sensors also
do not require a reference electrode and do not
consume analytes which is crucial in micro-scale
because of the low number of analytes available which
can bias an accurate detection. Overall, it appears that
optical chemical sensors are the most commonly used
component for integration into microfluidic devices.
This is because they are highly sensitive, inexpensive,
easy to miniaturise and are allow non-invasive mon-
itoring (Sun et al. 2015). Some of the demands of
optical oxygen sensors include high brightness, capa-
bility to be applied as a thin film (below 1 lm
thickness), good photostability, compatibility with
sample, cheap or established imaging systems, simple
and microfluidic production compatible preparation
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steps, compatibility with the chip materials and low or
no toxicity (Sun et al. 2015). Shaegh et al. (2016)
developed an optical multi-analyte sensing module
integrated with a microfluidic bioreactor for in situ
monitoring of pH and dissolved oxygen in the
circulating culture medium. The real time pH moni-
toring was detected by the level of light absorption by
the phenol red within the cell culture medium, and the
oxygen sensing was achieved by measuring the degree
of quenching in the luminescent intensity of an oxygen
sensitive fluorophore. The advantage of this platform
is that it is low cost and user friendly. It is also a
miniature and compact detection system which is
more desirable over bulky spectrophotometry or
microscopy techniques (Shaegh et al. 2016). Being
able to monitor the specific pH, it can indicate when
circulating medium should be replaced with fresh
medium. Whilst being able to monitor oxygen levels
in bioreactors is important as changes in oxygen
delivery to cells can cause variations in cellular
metabolism and physiological pathways.
Shin et al. (2017) developed a human liver-on-a-
chip microfluidic platform with integrated electro-
chemical biosensors, for the continual monitoring of
the metabolic activity of the organoids by measuring
the levels of secreted biomarkers for up to 7 days
which agreed with the data acquired by ELISA. The
versatile and robust microfluidic electrochemical
biosensor was capable of automated and continual
detection of soluble biomarkers, which is useful for
long-termmonitoring of human organoids during drug
toxicity studies or efficacy assessments of in vitro
platforms. The advantages of this system are the
automation of the operation of the electrode, label-free
antigen detection process requires minimum medium
depletion; regenerative capability of the electrode
surface upon saturation with captured antigens; and
cost-effectiveness due to the use of the miniaturized
electrodes and microfluidic platform, long term con-
tinual monitoring of biomarkers.
Conclusion
In summary, tissue engineered scaffolds and bioreac-
tors hold great potential for cell cultivation for future
target biotherapeutics. Furthermore, they offer a range
of additional advantages including (1) delivering
nutrients and eliminating waste/metabolites, (2)
mechanically stimulating cells, (3) building systemic
models, (4) enhancing pathways for cell–cell sig-
nalling and co-culture, and (5) enables long term
culture. Tissue engineered scaffolds mimicking extra-
cellular matrix have also been fabricated to augment
cell culture, by recreating innate microenvironments.
Biosensors are the future of tissue engineered scaffold
and bioreactors, as they enable non-invasive monitor-
ing of the cellular microenvironment. Real-time
monitoring of culture environments enables automatic
realignment of ideal biochemical parameters, such as
adjusting for nutrients and waste, to optimise cell
growth. We anticipate that the encouraging develop-
ments in this field provide great promise to further
under-stand the cellular microenvironment in tissue
engi-neering and regenerative medicine applications.
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